Dog Degenerative Joint Disease: Multimodal Pain Management

Osteoarthritis in dogs causes chronic progressive pain requiring multimodal management to maintain quality of life as the disease advances.

Key Facts

Osteoarthritis affects approximately 20% of dogs over 1 year and up to 80% of dogs over 8 years
Pain from OA is often underrecognized as behavioral changes are attributed to normal aging
NSAIDs are the cornerstone of OA pain management with several veterinary-approved options available
Nerve growth factor inhibitors including Librela (frunevetmab) offer a novel mechanism for pain control
Weight management is the single most impactful intervention for dogs with OA
Physical rehabilitation including hydrotherapy significantly improves mobility and muscle strength
Newer diagnostic tools including force plate gait analysis objectively quantify lameness severity

Welfare Considerations

Chronic arthritis pain significantly reduces quality of life through impaired mobility, interrupted sleep, and inability to engage in normal social and play behaviors. Dogs with undertreated OA show behavioral changes including irritability, reduced activity, and depression that owners may not connect to pain. Adequate multimodal pain management combining NSAIDs, weight control, physical therapy, and targeted supplements enables dogs to maintain meaningful activity and enjoyment of life.

What You Can Do

Evaluate older dogs for OA signs including slower rising, reluctance to climb stairs, and activity changes
Achieve and maintain healthy weight in arthritic dogs - even small weight reductions dramatically improve comfort
Use multiple pain management modalities together rather than relying on NSAIDs alone
Discuss Librela injection therapy for dogs not adequately controlled on oral NSAIDs
Pursue hydrotherapy and physiotherapy to maintain muscle mass and joint range of motion
Use validated pain scoring tools to objectively monitor OA pain and treatment response